skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 32  for All Library Resources

Results 1 2 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom
Material Type:
Article
Add to My Research

Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom

European heart journal, 2019-03, Vol.40 (12), p.986-993 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Cardiology. 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehy798 ;PMID: 30535072

Full text available

2
International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology
Material Type:
Article
Add to My Research

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology

European heart journal, 2018-06, Vol.39 (22), p.2032-2046 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Cardiology. 2018 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehy076 ;PMID: 29850871

Full text available

3
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences
Material Type:
Article
Add to My Research

Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences

European heart journal, 2021-01, Vol.42 (2), p.162-174 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa841 ;PMID: 33156912

Full text available

4
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

European heart journal, 2021-08, Vol.42 (32), p.3063-3073 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab424 ;PMID: 34263907

Full text available

5
Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy

European heart journal, 2021-05, Vol.42 (20), p.1988-1996 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab148 ;PMID: 33769460

Full text available

6
Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Material Type:
Article
Add to My Research

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)

European heart journal, 2022-02, Vol.43 (5), p.391-400 [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz173 ;PMID: 30938420

Full text available

7
A 20-year population study of peripartum cardiomyopathy
Material Type:
Article
Add to My Research

A 20-year population study of peripartum cardiomyopathy

European heart journal, 2023-12, Vol.44 (48), p.5128-5141 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. 2023 ;The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehad626 ;PMID: 37804234

Digital Resources/Online E-Resources

8
Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study
Material Type:
Article
Add to My Research

Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study

European heart journal, 2024-01, Vol.45 (3), p.233-235 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. 2023 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehad741 ;PMID: 37936240

Digital Resources/Online E-Resources

9
Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation
Material Type:
Article
Add to My Research

Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation

European heart journal, 2018-03, Vol.39 (10), p.853-860 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology. 2017 ;info:eu-repo/semantics/openAccess ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehx596 ;PMID: 29095976

Full text available

10
International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management
Material Type:
Article
Add to My Research

International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management

European heart journal, 2018-06, Vol.39 (22), p.2047-2062 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Cardiology 2018 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehy077 ;PMID: 29850820

Full text available

11
A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
Material Type:
Article
Add to My Research

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

European heart journal, 2019-06, Vol.40 (23), p.1850-1858 [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz103 ;PMID: 30915475

Full text available

12
Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
Material Type:
Article
Add to My Research

Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?

European heart journal, 2019-12, Vol.40 (45), p.3672-3681 [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. 2019 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz396 ;PMID: 31170284

Full text available

13
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction
Material Type:
Article
Add to My Research

Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction

European heart journal, 2021-07, Vol.42 (29), p.2842-2850 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab294 ;PMID: 34113975

Full text available

14
Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy

European heart journal, 2023-12, Vol.44 (48), p.5146-5158 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. 2023 ;The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehad372 ;PMID: 37431535

Digital Resources/Online E-Resources

15
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy

European heart journal, 2023-11, Vol.44 (44), p.4622-4633 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. 2023 ;The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehad637 ;PMID: 37804245

Digital Resources/Online E-Resources

16
Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation
Material Type:
Article
Add to My Research

Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation

European heart journal, 2022-03, Vol.43 (12), p.1234-1247 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. 2022 ;The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab893 ;PMID: 35134898

Full text available

17
Myocardial viability testing: all STICHed up, or about to be REVIVED?
Material Type:
Article
Add to My Research

Myocardial viability testing: all STICHed up, or about to be REVIVED?

European heart journal, 2022-01, Vol.43 (2), p.118-126 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab729 ;PMID: 34791132

Full text available

18
High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy
Material Type:
Article
Add to My Research

High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy

European heart journal, 2020-04, Vol.41 (14), p.1401-1410 [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. ;info:eu-repo/semantics/openAccess ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz570 ;PMID: 31504415

Full text available

19
Emery–Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure
Material Type:
Article
Add to My Research

Emery–Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure

European heart journal, 2023-12, Vol.44 (48), p.5064-5073 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. 2023 ;The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehad561 ;PMID: 37639473

Digital Resources/Online E-Resources

20
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
Material Type:
Article
Add to My Research

Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe

European heart journal, 2024-02, Vol.45 (7), p.538-548 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. 2024 ;The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehad799 ;PMID: 38195003

Digital Resources/Online E-Resources

Results 1 - 20 of 32  for All Library Resources

Results 1 2 next page

Searching Remote Databases, Please Wait